NEUMORA THERAPEUTICS, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2025-11-06: Form 10-Q; Item Smaller reporting company; As filed No.
- 2025-08-06: Form 10-Q; Item Smaller reporting company; As filed No.
- 2025-05-12: Form 10-Q; Item Smaller reporting company; As filed No.
- 2025-03-03: Form 10-K; Item Smaller reporting company; As filed No.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2025-11-06 | 10-Q | Smaller reporting company | No |
| 2025-08-06 | 10-Q | Smaller reporting company | No |
| 2025-05-12 | 10-Q | Smaller reporting company | No |
| 2025-03-03 | 10-K | Smaller reporting company | No |
| 2024-11-12 | 10-Q | Emerging growth company | Yes |
| 2024-08-06 | 10-Q | Emerging growth company | Yes |
| 2024-05-07 | 10-Q | Emerging growth company | Yes |
| 2024-03-07 | 10-K | Emerging growth company | Yes |
| 2024-03-07 | 10-K | Current in its reporting | No |
| 2023-11-01 | 10-Q | Emerging growth company | Yes |
| 2023-11-01 | 10-Q | Current in its reporting | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |